Medical device licence · 88359 · Class 2
MIC (MINIMUM INHIBITORY CONCENTRATION) TEST STRIP
Yes: licensed in Canada
Licence status Issued (active); first licensed February 28, 2012. It is in Health Canada’s list of active licences.
- Licence number
- 88359
- Licence holder
- Liofilchem S.R.L.Roseto Degli Abruzzi, TE, Italy
- Risk class
- Class II (low to moderate risk)
- Licence type
- Device Family
- First licensed
- February 28, 2012
- Devices covered
- 123
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- AMIKACIN
- AMOXICILLIAN-CLAVULANIC ACID
- AMOXICILLIN
- AMOXICILLIN/CLAVULANIC ACID (2/1)
- AMPHOTERICIN B
- AMPICILLIN
- AMPICILLIN*-SULBACTAM
- AMPICILLIN*/SULBACTAM (2/1)
- ANIDULAFUNGIN
- AZITHROMYCIN
- AZTREONAM
- AZTREONAM-AVIBACTAM
- BACITRACIN
- CASPOFUNGIN
- CEFACLOR
- CEFAZOLIN
- CEFEPIME
- CEFEPIME-ENMETAZOBACTAM
- CEFEPIME/CEFEPIME + CLAVULANIC ACID
- CEFIDEROCOL
- CEFIXIME
- CEFOPERAZONE-SULBACTAM (2/1)
- CEFOTAXIME
- CEFOTAXIME/CEFOTAXIME + CLAVULANIC ACID
- CEFOTETAN
- CEFOTETAN/CEFOTETAN + CLOXACILLIN
- CEFOXITIN
- CEFPIROME
- CEFPODOXIME
- CEFTAROLINE
- CEFTAZIDIME
- CEFTAZIDIME-AVIBACTAM
- CEFTAZIDIME/CEFTAZIDIME + CLAVULANIC ACID
- CEFTIBUTEN
- CEFTIZOXIME
- CEFTOBIPROLE
- CEFTOLOZANE-TAZOBACTAM
- CEFTRIAXONE
- CEFUROXIME
- CEPHALOTHIN
- CHLORAMPHENICOL
- CIPROFLOXACIN
- CLARITHROMYCIN
- CLINDAMYCIN
- CLOXACILLIN
- DALBAVANCIN
- DAPTOMYCIN
- DELAFLOXACIN
- DORIPENEM
- DOXYCYCLINE
- ERAVACYCLINE
- ERTAP/ERTAP+CLOXACILLIN
- ERTAPENEM
- ERTAPENEM/ERTAPENEM + BORONIC ACID
- ERYTHROMYCIN
- ETHAMBUTOL
- ETHIONAMIDE
- FLUCONAZOLE
- FLUCYTOSINE
- FOSFOMYCIN
- FOSMIDOMYCIN
- FUSIDIC ACID
- GATIFLOXACIN
- GEMIMFLOXACIN
- GENTAMICIN
- IMIPENEM
- IMIPENEM IMI
- IMIPENEM-RELEBACTAM
- IMIPENEM/IMIPENEM + EDTA
- IMIPENEM/IMIPENEM + EDTA
- ISAVUCONAZOLE
- ISONIAZIDE
- ITRACONAZOLE
- KANAMYCIN
- KETOCONAZOLE
- LEFAMULIN
- LEVOFLOXACIN
- LINEZOLID
- MECILLINAM
- MEROPENEM
- MEROPENEM-VABORBACTAM
- MEROPENEM/MEROPENEM + BORONIC ACID
- MEROPENEM/MEROPENEM + EDTA
- METRONIDAZOLE
- MICAFUNGIN
- MINOCYCLINE
- MOXIFLOXACIN
- MUPIROCIN
- NALIDIXIC ACID
- NETILMICIN
- NITROFURANTOIN
- NORFLOXACIN
- OFLOXACIN
- OMADACYCLINE
- OXACILLIN
- PEFLOXACIN
- PENICILLIN G
- PIPERACILLIN
- PIPERACILLIN/TAZOBACTAM
- PLAZOMICIN
- POLYMYXIN B
- POSACONAZOLE
- QUINUPRISTIN/DALFOPRISTIN
- RIFAMPICIN
- SPECTINOMYCIN
- SPIRAMYCIN
- STREPTOMYCIN
- SULBACTAM
- SULFAMETHOXAZOLE
- TEDIZOLID
- TEICOPLANIN
- TELAVANCIN
- TEMOCILLIN
- TETRACYCLINE
- TICARCILLIN
- TICARCILLIN/CLAVULANIC ACID
- TIGECYCLIN
- TOBRAMYCIN
- TRIMETHOPRIM
- TRIMETHOPRIM/SULFAMETHOXAZOLE (1/19)
- VANCOMYCIN
- VANCOMYCIN/TEICOPLANIN
- VORICONAZOLE
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.